MCID: CHS005
MIFTS: 20

Chest Wall Lymphoma

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Chest Wall Lymphoma

MalaCards integrated aliases for Chest Wall Lymphoma:

Name: Chest Wall Lymphoma 12 14 69
Malignant Neoplasm of Chest Wall Nos 12
Malignant Neoplasm of Chest Wall 12
Malignant Tumor of Chest Wall 12
Lymphoma of the Chest Wall 12
Lymphoma of Chest Wall 12
Chest Wall Cancer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6758
NCIt 47 C4580 C6712

Summaries for Chest Wall Lymphoma

Disease Ontology : 12 A thoracic cancer that is located in the chest wall.

MalaCards based summary : Chest Wall Lymphoma, also known as malignant neoplasm of chest wall nos, is related to chest wall bone cancer and lymphoma. An important gene associated with Chest Wall Lymphoma is SFTPD (Surfactant Protein D). The drugs Flucytosine and Fluorouracil have been mentioned in the context of this disorder. Affiliated tissues include breast and lymph node, and related phenotype is Negative genetic interaction between PTEN-/- and PTEN+/+.

Related Diseases for Chest Wall Lymphoma

Diseases related to Chest Wall Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 chest wall bone cancer 11.0
2 lymphoma 9.8
3 sternum lymphoma 9.5 SFTPD TWIST1

Symptoms & Phenotypes for Chest Wall Lymphoma

GenomeRNAi Phenotypes related to Chest Wall Lymphoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Negative genetic interaction between PTEN-/- and PTEN+/+ GR00255-A-3 8.62 SFTPD TWIST1

Drugs & Therapeutics for Chest Wall Lymphoma

Drugs for Chest Wall Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 6)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Flucytosine Approved Phase 1 2022-85-7 3366
2
Fluorouracil Approved Phase 1 51-21-8 3385
3
Miconazole Approved, Investigational, Vet_approved Phase 1 22916-47-8 4189
4 Antifungal Agents Phase 1
5 Anti-Infective Agents Phase 1
6 Antimetabolites Phase 1

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy Recruiting NCT01901094 Phase 3
2 A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) Recruiting NCT02576665 Phase 1 Toca FC

Search NIH Clinical Center for Chest Wall Lymphoma

Genetic Tests for Chest Wall Lymphoma

Anatomical Context for Chest Wall Lymphoma

MalaCards organs/tissues related to Chest Wall Lymphoma:

39
Breast, Lymph Node

Publications for Chest Wall Lymphoma

Articles related to Chest Wall Lymphoma:

id Title Authors Year
1
Primary chest wall lymphoma: A rare entity. ( 26458675 )
2015
2
Primary chest wall lymphoma with no history of tuberculous pyothorax: diagnosis and treatment. ( 19114192 )
2008

Variations for Chest Wall Lymphoma

Expression for Chest Wall Lymphoma

Search GEO for disease gene expression data for Chest Wall Lymphoma.

Pathways for Chest Wall Lymphoma

GO Terms for Chest Wall Lymphoma

Sources for Chest Wall Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....